作者: Urs Zingg , Bernard M. Smithers , David C. Gotley , Garett Smith , Ahmad Aly
DOI: 10.1245/S10434-010-1474-5
关键词: Surgical oncology 、 Medicine 、 Chemoradiotherapy 、 Cancer 、 Respiratory failure 、 Pulmonary Complication 、 Esophagectomy 、 Survival rate 、 Esophagus 、 Surgery
摘要: Background Most studies analyzing risk factors for pulmonary morbidity date from the early 1990s. Changes in technology and treatment such as minimally invasive esophagectomy (MIE) neoadjuvant mandate analysis of more contemporary cohorts.